BridgeBio Pharma, Inc. Gains 51.98%

Mon, Mar 06, 2023 at 07:09 PM
BridgeBio Pharma, Inc. Gains 51.98%

BridgeBio Pharma, Inc. (BBIO:NASDAQ) jumped higher at $16.52, representing a gain of 52%. On Mon, Mar 06, 2023, BBIO:NASDAQ touched a New 2-Week High of $16.52. The stock got featured on our News Catalysts scanner on Mon, Mar 06, 2023 at 05:33 PM in the 'MISCELLANEOUS' category. From Tue, Feb 21, 2023, the stock recorded 22.22% Up Days and 30.00% Green Days

About BridgeBio Pharma, Inc. (BBIO:NASDAQ)

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Oncology and Gene therapy.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.